YOUR HEALTH. A MORE INFORMED VIEW.
A nasal-swab molecular panel covering the twenty-seven listed viral and bacterial targets.
CLINICAL AUTHORDr Nirupama SabhapathySpecialist Clinical Pathology
THE PURPOSE BEHIND THE PANEL.
Respiratory symptoms overlap, so the panel looks for specific genetic targets rather than guessing from symptoms alone. The time since symptoms began, sample quality and clinical situation influence interpretation. A detected target should be discussed in context; a negative panel does not rule out every respiratory illness.
19named targets19 listed entries
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Only listed targets are covered. These panels do not automatically include SARS-CoV-2 unless it is named in the included list.
8named targets8 listed entries
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Only listed targets are covered. These panels do not automatically include SARS-CoV-2 unless it is named in the included list.
3laboratory assays3 included assays
These are the included laboratory tests or panels. Their named targets are shown in the other views; a target is a component of the package, not an additional item to purchase.
Only listed targets are covered. These panels do not automatically include SARS-CoV-2 unless it is named in the included list.
KNOW EXACTLY WHAT YOU ARE CHOOSING.
The headline count follows the source’s named-entry convention. Some entries may be grouped targets, mixtures or assay components; the exact source list below defines the scope.
27 named target entries · 3 included assays · 27 Pathogens
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Uses a molecular panel to look for eight listed respiratory bacterial targets in the submitted specimen.
INCLUDED COMPONENTS
Uses a molecular panel to look for ten listed respiratory viral targets, including influenza and RSV targets.
INCLUDED COMPONENTS
Uses a molecular panel to look for nine additional listed respiratory viral targets. It complements panel A.
INCLUDED COMPONENTS
Try a test or target name, or choose another health focus.
Checking a prescription?
Let’s make sure it matches.
THE RIGHT START DEPENDS ON YOU.
Choose the investigation around the question you want to discuss. Only listed targets are covered. These panels do not automatically include SARS-CoV-2 unless it is named in the included list.
Respiratory symptoms overlap, so the panel looks for specific genetic targets rather than guessing from symptoms alone. The time since symptoms began, sample quality and clinical situation influence interpretation. A detected target should be discussed in context; a negative panel does not rule out every respiratory illness.
Compare the full included list with your clinician’s request. Only listed targets are covered. These panels do not automatically include SARS-CoV-2 unless it is named in the included list.
Bring earlier results and the relevant symptom or treatment history. The clinician can decide whether this scope, a smaller test selection or a different investigation is the most useful next step.
MAKE THE SAMPLE COUNT.
Preparation follows the actual specimen and tests in Respiratory Viruses & Bacteria. Confirm your personal instructions before collection.
A personal checklist. Your care team confirms the instructions.
YOUR COLLECTION. YOUR CHOICE.
Both routes lead to the same defined package. Choose the location during checkout; this package waives the collection fee for its visit.
YOUR PLACE. THE SAME LABORATORY PATHWAY.
Discuss collection at your home, hotel or workplace in Dubai. The care team confirms the appropriate specimen, preparation and collection arrangements for this package.
Across DubaiTHE LABORATORY. READY TO WELCOME YOU.
Intel Lab · Deira
101–102, Al Hawai Building, Al Rigga Road, Al Muraqqabat, Deira, Dubai
DEIRA · DUBAI101–102Al Hawai Building
Al Rigga Road
FROM BOOKING TO UNDERSTANDING.
Follow Respiratory Viruses & Bacteria from your care bag to an informed conversation.
The right package. The right person.
Add Respiratory Viruses & Bacteria to your care bag. Book for yourself or assign the package to someone else. The care team can help match the selection to a request or prescription.
Preparation follows the test.
Confirm the instructions for nasal swab and the appropriate collection arrangements. Correct identification, specimen choice and timing support a useful result.
Laboratory work, behind the finding.
Intel Lab processes the sample and checks the report. The package lists 48 hours; collection timing and any additional laboratory checks may affect release.
A finding, placed in your context.
Read the report with the reason for testing. A clinician can explain unexpected findings, relevant limitations and whether any further assessment is appropriate.
MORE THAN A LIST OF NUMBERS.
Your report brings the measurements together. Explore the findings below to see which questions make the report more meaningful.
UNDERSTANDING YOUR REPORTNasal Swab
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. Only listed targets are covered. These panels do not automatically include SARS-CoV-2 unless it is named in the included list.
UNDERSTANDING YOUR REPORTNasal Swab
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. Only listed targets are covered. These panels do not automatically include SARS-CoV-2 unless it is named in the included list.
UNDERSTANDING YOUR REPORTNasal Swab
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
These are the included laboratory tests or panels. Their named targets are shown in the other views; a target is a component of the package, not an additional item to purchase. Only listed targets are covered. These panels do not automatically include SARS-CoV-2 unless it is named in the included list.
THE NEXT STEP IS PERSONAL.
Connect the laboratory findings with the reason for this specific test. A report supports the next clinical conversation; it does not decide it for you.
Review detected or undetected targets with the clinical team and the timing of illness. The result informs a defined question; it does not by itself decide treatment or explain every respiratory symptom.
Discuss this result with a clinician who knows the reason for testing. Further investigations or follow-up depend on the actual findings and your circumstances.
THE LABORATORY BEHIND YOUR RESULTS.
Intelligent Care brings the collection to you. Intel Lab brings the laboratory pathway, from sample handling to reporting.
Accurate patient details, the correct specimen and clear collection instructions are the first part of a reliable laboratory pathway. Follow the collection team’s instructions for the specimens required by this panel.
The laboratory’s analytical work and quality processes support the measurements in the report. Explore the laboratory’s published quality standards and accreditation scope for the detail behind its services.
Reporting connects the laboratory findings with their clinical use. Unexpected or significant results may need additional checks or communication with the referring clinician.
EXPERTISE WITH A NAME.
Laboratory content belongs with laboratory expertise. Explore the clinical profiles and their Dubai Health Authority directory records.
Clinical author
Laboratory Director · Intel Lab
Dr Nirupama Sabhapathy is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her published Intel Lab profile describes more than 25 years in medicine and her role as Laboratory Director.
Clinical reviewer
Specialist Clinical Pathology · Intel Lab
Dr Joyce Jose is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her public professional record includes pathology practice in the UAE and earlier experience as a professor at Gulf Medical University.
CHOOSE BY PURPOSE, NOT JUST COUNT.
Related packages may ask different questions. Compare their actual scope and discuss which, if any, is appropriate for you.
You are viewingOur most complete respiratory PCR screen: 27 targets covering 19 viruses plus 8 key respiratory bacteria including Streptococcus pneumoniae,…
A 10-target real-time PCR panel for the core cold and flu viruses (influenza A and B strains, RSV, parainfluenza and adenovirus) from a single nasal…
A 19-target respiratory PCR panel: everything in the Essential screen plus seasonal coronaviruses, rhinovirus, enterovirus, bocavirus, human…
A gold-standard real-time RT-PCR test for SARS-CoV-2 from a single nasal swab, with results in 24 hours.
Choosing for a particular need?
We can help you read the options.
BEFORE YOU BOOK.
Preparation, sample types, timing and what the package does—and does not—include.
A nasal-swab molecular panel covering the twenty-seven listed viral and bacterial targets. The full named inventory on this page is the scope of the package.
SARS-CoV-2 is not named in this package’s target list. COVID-19 PCR is a separate catalogue item; do not assume other coronavirus entries mean COVID-19 coverage.
No. It assesses the listed targets in the submitted specimen, not every infectious or non-infectious cause.
Not necessarily. Timing, recent infection and the clinical context matter when interpreting genetic-material detection.
No. A clinician assesses whether the detected finding is relevant and what treatment, if any, is appropriate.
The catalogue specifies a nasal swab. Follow the collector’s instructions and confirm any test-specific requirements.
Yes. Choose home collection across Dubai or a visit to Intel Lab in Deira. Any health package waives the collection fee for its own visit; separate appointments are assessed separately.
The package price is AED 899; the listed turnaround is 48 hours. Confirm collection and processing arrangements with the team. Turnaround is not a guarantee that every result will be released at one exact time.
Review relevant findings with a qualified clinician alongside the reason for testing, symptoms, medicines and prior results. The report may lead to reassurance about the tested question, confirmation, a targeted investigation or follow-up—not an automatic treatment decision.
YOUR NEXT STEP. AROUND YOU.
Respiratory Viruses & Bacteria · 27 Pathogens · Nasal Swab